1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow MT-2766 vaccine: new trials by email Literature Review of MT-2766 vaccine trials Research Report on MT-2766 vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19） MT-2766 High dose (3.75 µg), Placebo, MT-2766 Low dose - SARS-CoV-2 Infection | Phase 1 / Phase 2 | Terminated | Medicago | 128 | 2021-10-02 | 2023-11-07 |
COVID-19 (1)
Medicago (1)
Japan (1)